1 minute read
World Cancer Congress 2022
by UICC
After a four years hiatus, the World Cancer Congress returned on 18-20 October 2022. It took place in Geneva, a global health hub where UICC is headquartered.
The Congress brought together 2,000 participants from the cancer and NCD communities from 120 countries, with 1,600 delegates on-site interacting with wonderful speakers from around the world. 400 delegates connected remotely and were able to interact via a dedicated online platform.
World Cancer Congress 2022 was hosted by the Dutch Cancer Society, Gavi, the Vaccine Alliance, the Geneva University Hospitals (HUG), the French National Cancer Institute (INCa), the International Society of Paediatric Oncology (SIOP), the Nordic Cancer Union, the Norwegian Cancer Society, the Swedish Cancer Society and Unitaid, and was held in official partnership with four UN agencies: WHO, IARC, IAEA and UNAIDS. The Congress was sponsored by a record number of 55 partners, including Roche as a Platinum sponsor.
The programme covered all aspects of cancer control, from prevention to accessing care. Innovation, equity and patients’ perspectives were themes common to all the sessions.
A total of 160 sessions were presented by 662 speakers and each was recorded and made available through the Congress online platform. The platform remained open until the end of 2022, allowing all delegates to watch the content of the Congress at their own leisure.
The UICC Awards were presented during the closing ceremony to recognise the best abstracts, remarkable leadership in UICC member organisations and inspiring World Cancer Day campaigns. (see page 10)
Given the success of the event in Geneva and the ongoing challenges posed around the world due to the economic consequences of the pandemic, the Board of Directors has decided to hold the next World Cancer Congress in Geneva once again, 17-19 September 2024.
